Phytoalexin resveratrol attenuates the mutagenicity of the heterocyclic amines 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 802, Issue 1, 2004, Pages 217-223

  Boyce, Antony ^a   Doehmer, Johannes ^b   Gooderham, Nigel J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GenPharmTox BioTech AG   (Germany)

Author keywords

2 amino 1 methyl 6 phenylimidazo 4,5 b pyridine; 2 Amino 3,8 dimethylimidazo 4,5 f quinoxaline; Heterocyclic aromatic amines mutagenicity; Resveratrol

Indexed keywords

CARCINOGENS; CHEMOTHERAPY; COMPLEXATION; MUTAGENESIS; TOXICITY;

MUTAGENICITY;

AMINES;

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; ANTIMUTAGENIC AGENT; CARCINOGEN; HETEROCYCLIC AMINE; MUTAGENIC AGENT; PHYTOALEXIN; RESVERATROL;

ANIMAL CELL; ARTICLE; CELL STRAIN V 79; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; EUKARYOTIC CELL; HYPOTHESIS; MAMMAL CELL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM; TOXICOKINETICS;

ANIMALIA; BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; EUKARYOTA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 1242343768     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.10.057     Document Type: Article

References (35)

1. Doll R., Peto R. J. Natl. Cancer Inst. 66:1981;1191.
2. WCRF, Food, Nutrition and the Prevention of Cancer: A Global Perspective, AICR, Washington, USA, 1997.
3. Gerhardsson de Verdier M., Hagman U., Peters R.K., Steineck G., Overvick E. Int. J. Cancer. 49:1991;520.
4. Sugimura T., Sato S. Cancer Res. 43:1983;2415.
5. Yadollahi-Farsani M., Gooderham N.J., Davies D.S., Boobis A.R. Carcinogenesis. 17:1996;617.
6. Felton J.S., Knize M.G., Shen N.H., Andresen B.D., Bjeldanes L.F., Hatch F. Environ. Health Perspect. 67:1986;17.
7. Felton J.S., Knize M.G. Mutat. Res. 259:1991;205.
8. Murray S., Lynch A.M., Knize M.G., Gooderham N.J. J. Chromatogr. 616:1993;211.
9. Rich K., Murray B.P., Lewis I., Rendell N., Davies D.S., Gooderham N.J., Boobis A.R. Carcinogenesis. 13:1992;2221.
10. Zhao K., Murray S., Davies D.S., Boobis A.R., Gooderham N.J. Carcinogenesis. 15:1994;1285.
11. Butler M.A., Iwasaki M., Guengerich F.P., Kadlubar F.F. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7696.
12. Yamazaki H., Inui Y., Wrighton S.A., Guengerich F.P., Shimada T. Carcinogenesis. 16:1995;2167.
13. Buonarati M.H., Turteltaub K.W., Shen N.H., Felton J.S. Mutat. Res. 245:1990;185.
14. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher H., Fong H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Science. 275:1997;218.
15. Lu R., Serrero R.G. J. Cell. Phys. 304:1999;297.
16. Clifford A.J., Ebeler S.E., Ebeler J.D., Bills N.D., Hinrichs S.H., Teissedre P.L., Waterhouse A.L. Am. J. Clin. Nutr. 64:1996;748.
17. Jang D.S., Kang B.S., Ryu S.Y., Chang I.M., Min K.R., Kim Y. Biochem. Pharmacol. 57:1999;705.
18. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inue H., Jang M., Pezzuto J.M., Dannenberg A.J. J. Biol. Chem. 273:1998;21875.
19. Luch A., Schober W., Soballa V.J., Raab G., Greim H., Jacob J., Doehmer J., Seidel A. Chem. Res. Toxicol. 12:1999;353.
20. Crofts F.G., Strickland P.T., Sutter T.R. Carcinogenesis. 18:1997;1793.
21. Crofts F.G., Sutter T.R., Stickland P.T. Carcinogenesis. 19:1998;1969.
22. Uenobe F., Nakamura S., Miyazawa M. Mutat. Res. 373:1997;197.
23. Gooderham N.J., Murray S., Rice J.C., Boobis A.R., Davies D.S. Drug Metab. Rev. 20:1989;285.
24. Lynch A.M., Knize M.G., Boobis A.R., Gooderham N.J., Davies D.S., Murray S. Cancer Res. 52:1992;6216.
25. Ushiyama H., Wakabayashi K., Hirose M., Itoh H., Sugimura T., Nagao M. Carcinogenesis. 12:1991;1417.
26. Zhu H., Boobis A.R., Gooderham N.J. Cancer Res. 60:2000;1283.
27. Duc R., Leong-Morgenthaler P.M. Mutat. Res. 486:2001;155.
28. Hirose Y., Sugie S.N., Yoshimi N., Matsunaga K., Hara A., Mori H. Cancer Lett. 123:1998;167.
29. Chun Y.J., Kim M.Y., Guengerich F.P. Biochem. Biophys. Res. Commun. 262:1999;20.
30. Babich H., Reisbaum A.G., Zuckerbraun H.L. Toxicol. Lett. 114:2000;143.
31. Potter G.A., Patterson L.H., Wanogho E., Perry P.J., Butler P.C., Ijaz T., Ruparelia K.C., Lamb J.H., Farmer P., Stanley L.A., Burke M.D. Br. J. Cancer. 86:2002;774.
32. Guengerich F.P., Chun Y.-J., Kim D., Gillam E.M.J., Shimada T. Mutat. Res. 523-534:2003;173.
33. Sun N.J., Woo S.H., Cassady J.M., Snapka R.M. J. Nat. Prod. 61:1998;362.
34. Jang M., Pezzuto J.M. Drugs Exp. Clin. Res. 25:1999;65.
35. Holmes-McNary M., Baldwin A.S. Jr. Cancer Res. 60:2000;3477.